Horizon Technology Finance Corporation 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-21 3:46 pm Purchase | 2023-07-11 | 13G | Evelo Biosciences, Inc. EVLO | Horizon Technology Finance Corp HRZN | 2,164,502 11.500% | 2,164,502 (New Position) | Filing |